Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Adenoviruses are potent vectors for inducing and boosting cellular immunity to encoded recombinant antigens. However, the widespread seroprevalence of neutralizing antibodies to common human adenovirus serotypes limits their use. Simian adenoviruses do not suffer from the same drawbacks. We have con...
Main Authors: | Antrobus, R, Coughlan, L, Berthoud, T, Dicks, MD, Hill, A, Lambe, T, Gilbert, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2014
|
Registos relacionados
-
Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
Por: Antrobus, R, et al.
Publicado em: (2014) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Por: Folegatti, P, et al.
Publicado em: (2019) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Por: Pedro M. Folegatti, et al.
Publicado em: (2019-05-01) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Por: Zhang, C, et al.
Publicado em: (2023) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Por: Cheng Zhang, et al.
Publicado em: (2023-06-01)